Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCeiba Investme. Regulatory News (CBA)

Share Price Information for Ceiba Investme. (CBA)

Share Price is delayed by 15 minutes
Get Live Data
29.00    0.00 (0.00%)
Bid:
24.00
Ask:
34.00
Spread: 10.00 (41.667%)
Market Cap: £47.91m
CBA Live PriceLast checked at - London Stock Exchange

Intraday Ceiba Investme. Share Chart

Statement re Update from the Chairman

7 Oct 2024 07:00

RNS Number : 0676H
Ceiba Investments Limited
07 October 2024
 

CEIBA INVESTMENTS LIMITED

(the "Company")

(TICKER: CBA, ISIN: GG00BFMDJH11)

Legal Entity Identifier: 213800XGY151JV5B1E88

 

UPDATE FROM THE CHAIRMAN

On 27 September 2024, the Company published its 30 June 2024 unaudited interim financial statements - https://ceibainvest.com/wp-content/uploads/2024/09/20240630-CBA-ICFS.pdf

At the latest Board meeting of the Company, the Board instructed Management to enter into discussions with Bondholders regarding the possibility of restructuring the €25 million 10% Convertible Bonds 2026 to change the payment schedule from a single €25 million bullet payment due on 31 March 2026 to five equal annual instalments of €5 million, to be made starting in 2025. If no agreement can be reached with Bondholders regarding a restructuring, the Board will consider prepaying €10 million under the Convertible Bonds prior to 31 March 2026, and attracting €15 million in new finance to pay the remainder of the Convertible Bonds on 31 March 2026.

Once Management and the Board gain additional confidence in the Company's cash flows and financial position, and payments to Bondholders can be made according to the new schedule, the Board would be in a position to review whether the possibility exists of using part of the free cash-flow of the Company to make distributions to shareholders and buy back Shares in the Company, actions which - given the discount at which Shares are presently trading - are both considered attractive.

As per the annual general meeting held on 18 June 2024, the Company has the authority to buy back Shares, provided that: (i) the maximum number of Shares that may be purchased is 10 per cent. of the aggregate number of Shares in issue at the date of the annual general meeting; (ii) the minimum price which may be paid for a Share is £0.01; and (iii) the maximum price which may be paid for a Share is the higher of: (a) an amount equal to 105 per cent. of the average of the mid-market values of a Share taken from the London Stock Exchange Daily Official List for the five business days before the purchase is made; and (b) the higher of the price of the last independent trade or the highest current independent bid for Shares on the London Stock Exchange at the time the purchase is carried out.

John A. Herring

Chairman

For further information, please contact:

 Sebastiaan Berger  

Via NSM Funds Limited

Singer Capital Markets

James Maxwell / Finn Gordon (Corporate Finance)

James Waterlow (Sales)

Tel: +44 (0)20 7496 3000

NSM Funds Limited

Tel: +44(0)1481 743030

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRDZMGGVDGGDZM
12
Date   Source Headline
5th Jun 20268:33 amRNSTrading Update
27th May 20263:39 pmRNSHolding(s) in Company
22nd May 20262:30 pmRNSHolding(s) in Company
20th May 20263:37 pmRNSHolding(s) in Company
19th May 20261:07 pmRNSHolding(s) in Company
15th May 202612:40 pmRNSDirector/PDMR Shareholding
12th May 20267:00 amRNSIssue of Equity
30th Apr 20267:00 amRNSAnnual Financial Report
14th Apr 20264:46 pmRNSResult of EGM
1st Apr 202611:21 amRNSFurther re Second Amendment of Bond Instrument
27th Feb 20265:14 pmRNSFurther re Second Amendment of Bond Instrument
27th Feb 20262:26 pmRNSDirectorate change
13th Feb 20265:13 pmRNSStatement re Second Amendment of Bond Instrument
13th Feb 20263:20 pmRNSDirector Declaration
12th Feb 20265:32 pmRNSChange of Auditor
5th Feb 20267:00 amRNSTrading Update - Consultation with Bondholders
26th Jan 20263:36 pmRNSDirector/PDMR Shareholding
23rd Dec 20251:39 pmRNSNet Asset Value(s)
4th Dec 20253:25 pmRNSAppointment of Senior Independent Director
2nd Oct 20252:48 pmRNSDirector/PDMR Shareholding
29th Sep 20257:00 amRNSHalf-year Report
12th Sep 20253:16 pmRNSDirectorate Change
8th Jul 20257:00 amRNSTrading Update - Payment to Bondholders
4th Jul 202512:49 pmRNSDirectorate Change
3rd Jul 20253:14 pmRNSResult of AGM
1st Jul 20251:35 pmRNSNet Asset Value(s)
30th Apr 20257:00 amRNSAnnual Financial Report
28th Apr 202510:26 amRNSDirectorate Change
3rd Feb 20257:00 amRNSStatement re Amendment of Bond Instrument
13th Jan 20255:51 pmRNSStatement re Amendment of Bond Instrument
11th Dec 20241:31 pmRNSNet Asset Value(s)
7th Oct 202410:55 amRNSDirector/PDMR Shareholding
7th Oct 20247:00 amRNSStatement re Update from the Chairman
27th Sep 20247:00 amRNSHalf-year Report to 30 June 2024
13th Aug 20248:36 amRNSDirectorate Change
20th Jun 20243:09 pmRNSDirector/PDMR Shareholding
20th Jun 20247:00 amRNSNet Asset Value(s)
18th Jun 20244:53 pmRNSResult of AGM
30th Apr 20247:00 amRNSAnnual Financial Report
25th Mar 202411:03 amRNSDirectorate Change
17th Jan 20247:00 amRNSInvestment Update
27th Dec 20239:17 amRNSNet Asset Value(s)
18th Dec 20238:54 amRNSDirector/PDMR Shareholding
3rd Nov 202310:36 amRNSHolding(s) in Company
1st Nov 20239:05 amRNSDirector/PDMR Shareholding
27th Oct 202311:11 amRNSDirector/PDMR Shareholding
16th Oct 20238:37 amRNSAppointment of Non-Executive Director
12th Oct 20234:26 pmRNSDirector/PDMR Shareholding
5th Oct 202310:24 amRNSDirector/PDMR Shareholding
29th Sep 20237:00 amRNSHalf-year Report
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.